Premium
Atea Pharmaceuticals Inc (AVIR)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-18 | Mr. Bruno LucidiIndependent Director | 29,60k | 0,00 | Derivative Exercise and Retained Stock | - | 142,35k | 26,25% |
| 2026-06-18 | Mr. Franklin M. BergerLead Independent Director | 29,60k | 0,00 | Derivative Exercise and Retained Stock | - | 536,10k | 5,84% |
| 2026-06-18 | Ms. Barbara G. DuncanIndependent Director | 29,60k | 0,00 | Derivative Exercise and Retained Stock | - | 92,35k | 47,17% |
| 2026-06-18 | Dr. Jerome M. AdamsIndependent Director | 29,60k | 0,00 | Derivative Exercise and Retained Stock | - | 92,35k | 47,17% |
| 2026-06-18 | Dr. Bruce W. PolskyIndependent Director | 29,60k | 0,00 | Derivative Exercise and Retained Stock | - | 124,81k | 31,09% |
| 2026-06-18 | Dr. Polly A. MurphyIndependent Director | 29,60k | 0,00 | Derivative Exercise and Retained Stock | - | 121,75k | 32,12% |
| 2026-05-18 | Dr. Polly A. MurphyIndependent Director | 6,10k | 25,45k | Achat | 4,17 | 92,15k | 7,09% |
| 2026-03-11 | Ms. Andrea J. CorcoranCFO, Exec. VP of Legal & Secretary | 60,00k | 74,40k | Derivative Exercise and Retained Stock | 1,24 | 823,58k | 7,86% |
| 2026-01-31 | Dr. Maria Arantxa HorgaChief Medical Officer | 35,21k | 0,00 | Derivative Exercise and Retained Stock | - | 96,09k | 57,84% |
| 2026-01-31 | Dr. Maria Arantxa HorgaChief Medical Officer | -16,07k | 68,15k | Derivative Exercise and Sale | 4,24 | 96,09k | - |
| 2026-01-31 | Mr. John F. VavrickaChief Commercial Officer | 30,51k | 0,00 | Derivative Exercise and Retained Stock | - | 165,10k | 22,67% |
| 2026-01-31 | Mr. John F. VavrickaChief Commercial Officer | -11,57k | 49,06k | Derivative Exercise and Sale | 4,24 | 165,10k | - |
| 2026-01-31 | Ms. Andrea J. CorcoranCFO, Exec. VP of Legal & Secretary | 38,76k | 0,00 | Derivative Exercise and Retained Stock | - | 763,58k | 5,35% |
| 2026-01-31 | Ms. Andrea J. CorcoranCFO, Exec. VP of Legal & Secretary | -16,10k | 68,28k | Derivative Exercise and Sale | 4,24 | 763,58k | - |
| 2026-01-31 | Dr. Janet M. J. HammondChief Development Officer | 43,91k | 0,00 | Derivative Exercise and Retained Stock | - | 127,67k | 52,43% |
| 2026-01-31 | Dr. Janet M. J. HammondChief Development Officer | -14,14k | 59,94k | Derivative Exercise and Sale | 4,24 | 127,67k | - |
| 2026-01-31 | Dr. Jean-Pierre SommadossiFounder, Chairman, CEO & President | 466,89k | 372,00k | Derivative Exercise and Retained Stock | 1,24 | 6,63M | 7,57% |
| 2026-01-31 | Dr. Jean-Pierre SommadossiFounder, Chairman, CEO & President | -106,09k | 449,83k | Derivative Exercise and Sale | 4,24 | 6,63M | - |
| 2026-01-31 | Mr. Wayne FosterExec. VP of Finance & CAO | 29,20k | 0,00 | Derivative Exercise and Retained Stock | - | 79,33k | 58,25% |
| 2026-01-31 | Mr. Wayne FosterExec. VP of Finance & CAO | -12,13k | 51,44k | Derivative Exercise and Sale | 4,24 | 79,33k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
